Presentation is loading. Please wait.

Presentation is loading. Please wait.

Utah’s APCD as a Stand-alone Opioid Monitoring Tool

Published byAlaina Pierce Modified over 6 years ago

Similar presentations

Presentation on theme: "Utah’s APCD as a Stand-alone Opioid Monitoring Tool"— Presentation transcript:

1 Utah’s APCD as a Stand-alone Opioid Monitoring Tool
Office of Health Care Statistics Utah Department of Health

2 Introduction Sterling Petersen, Analytics Lead
Office of Health Care Statistics Utah Department of Health

3 Office of Health Care Statistics (OHCS)
Housed within the Center for Health Data and Informatics (CHDI) at the Utah Department of Health (UDOH) Collects, analyzes, and disseminates data Healthcare Facility Discharge Data Inpatient (1992–Current) ED (1996–Current) Ambulatory Surgery (1996–Current) APCD (2013–Current) HEDIS CAHPS

4 All Payer Claims Database (APCD)
Submitted on a monthly basis, processed bi-annually 2013–Current Anticipate moving to quarterly processing 2019Q1 About 40 data streams Covers approximately 75% of the commercial market Medicaid About 2/3 of Medicare Advantage/Part C market Unknown portion of the Medicare Part D market

5 Controlled Substance Database (CSD)
Utah’s prescription drug monitoring program (PDMP) Maintained by the Division of Occupational and Professional Licensing (DOPL) at Utah Department of Commerce Collects dispensing information on Schedule II–V drugs Retail pharmacies Institutional pharmacies Outpatient hospital pharmacies In-state/Out-of-state mail order pharmacies

6 All Payer Claims Database (APCD)
Data Release Policies All Payer Claims Database (APCD) Datasets available for internal and external researchers after approval “Limited Use” “Research” Controlled Substance Database (CSD) Datasets available for internal researchers at the Utah Department of Commerce and the Utah Department of Health after approval Narrow access provision for external partners

7 APCD as a Stand-alone Opioid Monitoring Tool?
Coverage APCD Most commercial, Medicaid, some Medicare CSD All commercial, Medicaid, Medicare, cash-pay

8 APCD as a Stand-alone Opioid Monitoring Tool?
Data Quality APCD Continuous quality monitoring by internal and external personnel Feedback from external data users Linked person-centric database CSD Enhanced quality monitoring in early stages of development No built-in longitudinal person identifier

9 APCD as a Standalone Opioid Monitoring Tool?
Measurement Results - CY2017 Pharmacy Quality Alliance’s Opioid-Related Measures Concurrent Use of Opioids and Benzodiazepines (COB) Use of Opioids at High Dosage in Persons Without Cancer (OHD) (NQF #2940) Use of Opioids from Multiple Providers in Persons Without Cancer (OMP) (NQF #2950) Use of Opioids at High Dosage and from Multiple Providers in Persons Without Cancer (OHDMP) (NQF #2951)

10 Concurrent Use of Opioids and Benzodiazepines (COB)
The percentage of individuals 18 years and older with concurrent use of prescription opioids and benzodiazepines APCD 22,682 / 110,889 ≈ 20.5% CSD 38,421 / 203,040 ≈ 18.9% Cancer and hospice exclusion omitted

11 Use of Opioids at High Dosage in Persons Without Cancer (OHD)
The proportion of individuals from the denominator receiving prescriptions for opioids with a daily dosage greater than 120 morphine milligram equivalents (MME) for 90 consecutive days or longer APCD 5,788 / 105,424 ≈ 5.5% CSD 10,304 / 192,763 ≈ 5.3% Cancer and hospice exclusion omitted

12 Use of Opioids from Multiple Providers in Persons Without Cancer (OMP)
The proportion of individuals from the denominator receiving prescriptions for opioids from four (4) or more prescribers AND four (4) or more pharmacies APCD 2,856 / 105,424 ≈ 2.7% CSD 4,652 / 192,763 ≈ 2.4% Cancer and hospice exclusion omitted

13 Cancer and hospice exclusion omitted
Use of Opioids at High Dosage and from Multiple Providers in Persons Without Cancer (OHDMP) The proportion of individuals from the denominator receiving prescriptions for opioids with a daily dosage greater than 120 morphine milligram equivalents (MME) for 90 consecutive days or longer AND who received opioid prescriptions from four (4) or more prescribers AND four (4) or more pharmacies APCD 203 / 105,424 ≈ 0.2% CSD 382 / 192,763 ≈ 0.2% Cancer and hospice exclusion omitted

14 Basic Diagnostics (APCD | CSD)
Age Group Female Male Unknown 18-24 64.9% | 62.1% 35.1% | 37.6% 0.0% | 0.3% 25-34 63.7% | 59.0% 36.3% | 40.6% 0.0% | 0.4% 35-44 59.0% | 56.0% 41.0% | 43.6% 0.0% | 0.5% 45-54 58.5% | 56.2% 41.4% | 43.3% 55-64 56.4% | 53.8% 43.5% | 45.6% 65+ 62.9% | 59.4% 37.1% | 39.9% 0.0% | 0.7% Total 60.1% | 57.1% 39.9% | 42.4%

15 Basic Diagnostics (APCD | CSD)
Age Group Gender Average Total Days Supply Max Total Days Supply Average Unique Days of Service Max Unique Days of Service 18-24 Female 75.8 | 76.6 1527 | 1412 6 | 6 72 | 73 Male 77.9 | 77.0 834 | 803 5 | 5 26 | 47 25-34 128.6 | 126.8 1298 | 1272 7 | 7 81 | 85 137.0 | 136.7 1095 | 1256 61 | 61 35-44 164.6 | 162.1 1065 | 1532 8 | 8 72 | 93 170.3 | 167.3 1118 | 1069 64 | 77 45-54 180.9 | 174.9 1074 | 1109 65 | 67 178.6 | 176.3 1467 | 3114 142 | 354 55-64 182.9 | 173.9 1213 | 1345 59 | 70 181.7 | 177.9 1367 | 1578 59 | 67 65+ 164.2 | 147.1 1039 | 1019 7 | 6 66 | 72 159.9 | 151.2 1332 | 1384 70 | 73

16 Basic Diagnostics (APCD | CSD)

17 Results by Age Groups (ApCD | CSD)
COB OHD OMP Age Group APCD CSD 18-24 7.7% 8.0% 1.1% 1.3% 6.7% 4.9% 25-34 16.9% 15.8% 4.2% 4.5% 5.9% 35-44 21.9% 20.5% 6.9% 7.1% 4.6% 45-54 24.0% 22.3% 7.6% 2.9% 2.7% 55-64 23.6% 21.6% 7.3% 2.2% 1.8% 65+ 17.4% 16.1% 3.0% 2.8% 1.0% 0.8% Total 21.0% 19.7% 6.3% 6.5% 3.2%

18 Conclusion and Looking Forward
Utah’s APCD and CSD yield comparable results for basic measures We only examined CY2017 due to constraints with the CSD. A multi-year investigation might be useful Utah’s APCD might be an appropriate alternative to the CSD for some opioid-related analyses

Download ppt "Utah’s APCD as a Stand-alone Opioid Monitoring Tool"

Similar presentations

Barbara Rudolph, PhD, MSSW NAHDO Consultant. To enhance the value of statewide APCDs by cataloging measures and reporting practices To develop and disseminate.

Barbara Rudolph, PhD, MSSW NAHDO Consultant. To enhance the value of statewide APCDs by cataloging measures and reporting practices To develop and disseminate.
1 Proprietary and Confidential 1 Identification of Potentially Avoidable Emergency Department Visits Using Claims Data APHA Session 4204.0: Advances in.

1 Proprietary and Confidential 1 Identification of Potentially Avoidable Emergency Department Visits Using Claims Data APHA Session : Advances in.
Department of Vermont Health Access Vermont Blueprint for Health: Using APCD to Evaluate Health Care Reform Pat Jones, MS Blueprint Assistant Director.

Department of Vermont Health Access Vermont Blueprint for Health: Using APCD to Evaluate Health Care Reform Pat Jones, MS Blueprint Assistant Director.
VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.

VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.
Pharmacy Department Overview & Prescription Regulations

Pharmacy Department Overview & Prescription Regulations
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.

Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
Adoption of Health Information Technology among U.S. Ambulatory and Long-term Care Providers by Esther Hing, M.P.H., and Anita Bercovitz, Ph.D National.

Adoption of Health Information Technology among U.S. Ambulatory and Long-term Care Providers by Esther Hing, M.P.H., and Anita Bercovitz, Ph.D National.
Technology Council of Maryland Health IT Forum “Big Data” and the Real World.

Technology Council of Maryland Health IT Forum “Big Data” and the Real World.
Public Employees Benefits Board April 23, 2002. 2003 PEBB Procurement Bid Alternatives.

Public Employees Benefits Board April 23, PEBB Procurement Bid Alternatives.
Monthly APCD User Workgroup Webinar May 27 th, 2014.

Monthly APCD User Workgroup Webinar May 27 th, 2014.
An Overview of NCQA’s Relative Resource Use Measures.

An Overview of NCQA’s Relative Resource Use Measures.
1 Proprietary and Confidential 1 Geographic Variation in the Rates of Chiropractic Manipulation Treatment in Northern New England APHA Session 3222.0:

1 Proprietary and Confidential 1 Geographic Variation in the Rates of Chiropractic Manipulation Treatment in Northern New England APHA Session :
The Prescription Behavior Surveillance System: Applications of De-identified PDMP Data in Public Health Surveillance Rx Abuse Summit April 23, 2014 Peter.

The Prescription Behavior Surveillance System: Applications of De-identified PDMP Data in Public Health Surveillance Rx Abuse Summit April 23, 2014 Peter.
Snapshot of IMS LifeLink Claims Database 10% Random Sample

Snapshot of IMS LifeLink Claims Database 10% Random Sample
Overview of the National Health Care Survey Thomas McLemore Division of Health Care Statistics October 10, 2003 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.

Overview of the National Health Care Survey Thomas McLemore Division of Health Care Statistics October 10, 2003 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
Accessing Aggregated Population Health Data from Select Tools of the NCHS A presentation at the Knowledge 4 Equity Conference James M. Craver November.

Accessing Aggregated Population Health Data from Select Tools of the NCHS A presentation at the Knowledge 4 Equity Conference James M. Craver November.
Medicare Claims Dashboard Application Overview. THE CHALLENGE The challenge being put forth is to develop an online dashboard for researchers or other.

Medicare Claims Dashboard Application Overview. THE CHALLENGE The challenge being put forth is to develop an online dashboard for researchers or other.
July 31, 2009Prepared by the Maine Health Information Center Overview of All Payer Claims Data Suanne Singer, Senior Consultant Maine Health Information.

July 31, 2009Prepared by the Maine Health Information Center Overview of All Payer Claims Data Suanne Singer, Senior Consultant Maine Health Information.
Available Types of National Drug Use Data DSARM Advisory Committee Meeting Silver Spring, Maryland May 18, 2005 Judy Staffa, PhD, RPh, Epidemiology Team.

Available Types of National Drug Use Data DSARM Advisory Committee Meeting Silver Spring, Maryland May 18, 2005 Judy Staffa, PhD, RPh, Epidemiology Team.
Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.

Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.

Similar presentations

Ads by Google